Qiagen NV Debuts QIAsymphony Connect at AMP Annual Meeting
Qiagen NV will debut its QIAsymphony Connect platform at the AMP annual meeting in Boston from November 11-15, 2025. The event will highlight advancements in precision oncology, including early-access data from partnerships and new genomic profiling workflows. This news was generated by Public Technologies and is for informational purposes only.
Qiagen NV will attend the Association for Molecular Pathology (AMP) annual meeting from November 11-15, 2025, in Boston. At the event, Qiagen will debut QIAsymphony Connect, its next-generation automated nucleic acid purification platform, and showcase advancements in precision oncology, including early-access data from key partnerships and new workflows for genomic profiling. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qiagen NV published the original content used to generate this news brief via Business Wire (Ref. ID: 20251109840334) on November 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
